▪ Impaired immune system due to immunosuppressive diseases such as AIDS and
HIV or use of immunosuppressive medications.
▪ Patients with history of diseases stimulated by heat, such as recurrent Herpes
Simplex in the treatment area, may be treated only following a prophylactic
regime.
▪ Poorly controlled endocrine disorders, such as diabetes or thyroid dysfunction
and hormonal virilization.
▪ Any active skin condition in the treatment area, such as sores, psoriasis, eczema,
and rash.
▪ History of skin disorders, keloids, abnormal wound healing, as well as very dry
and fragile skin.
▪ History of bleeding coagulopathies.
▪ Any facial surgery performed within a year prior to treatment.
▪ Facial dermabrasion, facial resurfacing, or deep chemical peeling within the last
three months, if face is treated.
▪ Having received treatment with light, laser, RF, or other devices in the treated
area within 2-3 weeks for non-ablative procedures, and 6-12 weeks for ablative
fractional laser resurfacing (according to treatment severity) prior to treatment,
except special recommendations.
▪ Use of Isotretinoin (Accutane®) within 6 months prior to treatment.
▪ Use of non-steroidal anti-inflammatory drugs (NSAIDS, e.g., ibuprofen-containing
agents) one week before and after each treatment session, as per the
practitioner’s discretion.
▪ Treating over tattoo or permanent makeup.
▪ Treating over the lips.
▪ Treating over eyebrows or other hair bearing surfaces.
▪ Treat patients with skin types VI and dark VI with caution.
▪ Excessively tanned skin from sun, tanning beds or tanning creams and sprays
within the last two weeks.
▪ As per the practitioner's discretion, refrain from treating any condition that
might make it unsafe for the patient.
To Next Page
Loading...
